Close
ACHEMA MIDDLE EAST 2026

Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

The 64th annual meeting of the American Society of Hematology, a prestigious venue for some of their field's most significant research, will be held...

India Seeks Better Pharma Market Access In The UK: Official

As a part of the proposed free trade deal with Britain, India is looking at expanding access to markets for its pharmaceutical products in...

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

The effectiveness of aducanumab and donanemab in treating Alzheimer's disease (AD) was successfully simulated using a novel computer model, demonstrating how a steady rise...

CPhI Pharma Index Shows Unprecedented Global Pharma Optimism

Pharma confidence in growth, innovation, and process efficiency has reached record highs, according to the results of the CPhI's 2022 Pharma Index poll, which...

$2 Million Gene Therapy Might Become The Standard In The US

In recent years, the high cost of gene therapies has emerged as a major barrier to the development of personalised medicines. Most notably, bluebird...

Cancer Medicine Prices Jump 53% In Five Years In The U.S

According to new research by Katie Porter, U.S. Democratic Representative and a consumer bankruptcy law professor vying for re-election in California, the cost of...

Food And Drug Administration User Fee Has Been Reauthorized

As anticipated, Congress swiftly reauthorized four important user fee programmes as part of a bill that was essential to passing in order to continue...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...